Literature DB >> 10695924

Lipoproteins modify the macrophage uptake of triacylglycerol emulsion and of zymosan particles by similar mechanisms.

M D Carvalho1, V E Tobias, C M Vendrame, A F Shimabukuro, M Gidlund, E C Quintão.   

Abstract

The uptake of lipids and formation of foam cells are key events in atherosclerosis and in eruptive xanthomata formation in primary hyperchylomicronemia. Here we have compared the influence of low density lipoprotein (LDL), oxidized LDL (oxLDL), high density lipoprotein (HDL), and delipidated HDL (apoHDL) on the uptake by macrophages of zymosan (an insoluble fraction of yeast cell walls) and of triglyceride-rich emulsion (EM) particles that resemble chylomicrons, but, like zymosan, are equally devoid of protein components. Zymosan internalization is known to occur through unspecific phagocytosis, whereas natural chylomicrons are taken up by several specific lipoprotein receptors. We found that phagocytosis is not promoted as much by oxLDL as by normal LDL. HDL-coated zymosan was found to be inert and apoHDL slightly enhanced phagocytosis. LDL and apoHDL promoted the uptake of EM while oxLDL and HDL significantly inhibited the uptake. Therefore, the data support that HDL, and not apoHDL, particles inhibit EM uptake. We concluded that by using lipoprotein-coated zymosan particles, we could demonstrate different biological effects of LDL, oxLDL, HDL, and apoHDL on macrophage phagocytosis and that this method could be useful to delineate components of the various lipoproteins important for the propagation or inhibition of the formation of foam cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10695924     DOI: 10.1007/s11745-000-0494-1

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  32 in total

1.  Monoclonal antibodies against LDL further enhance macrophage uptake of LDL aggregates.

Authors:  J C Khoo; E Miller; F Pio; D Steinberg; J L Witztum
Journal:  Arterioscler Thromb       Date:  1992-11

2.  On the composition of zymosan.

Authors:  F J DI CARLO; J V FIORE
Journal:  Science       Date:  1958-04-04       Impact factor: 47.728

Review 3.  Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity.

Authors:  D Steinberg; S Parthasarathy; T E Carew; J C Khoo; J L Witztum
Journal:  N Engl J Med       Date:  1989-04-06       Impact factor: 91.245

4.  Competition between chylomicrons and their remnants for plasma removal: a study with artificial emulsion models of chylomicrons.

Authors:  H C Oliveira; M H Hirata; T G Redgrave; R C Maranhão
Journal:  Biochim Biophys Acta       Date:  1988-02-04

5.  Increased macrophage uptake of irreversibly glycated albumin modified-low density lipoproteins of normal and diabetic subjects is mediated by non-saturable mechanisms.

Authors:  A Dobrian; V Lazar; D Tirziu; M Simionescu
Journal:  Biochim Biophys Acta       Date:  1996-10-07

6.  Induction of granulocyte histaminase release by particle-bound complement C3 cleavage products (C3b, C3bi) and IgG.

Authors:  J Melamed; R G Medicus; M A Arnaout; H R Colten
Journal:  J Immunol       Date:  1983-07       Impact factor: 5.422

Review 7.  Novel members of the low density lipoprotein receptor superfamily and their potential roles in lipid metabolism.

Authors:  W J Schneider; J Nimpf; H Bujo
Journal:  Curr Opin Lipidol       Date:  1997-10       Impact factor: 4.776

8.  Iron and copper promote modification of low density lipoprotein by human arterial smooth muscle cells in culture.

Authors:  J W Heinecke; H Rosen; A Chait
Journal:  J Clin Invest       Date:  1984-11       Impact factor: 14.808

9.  High-density lipoprotein subfractions as markers of early atherosclerosis. PCVMETRA Group. Prévention Cardio-Vasculaire en Medecene du Travail.

Authors:  V Atger; P Giral; A Simon; M Cambillau; J Levenson; J Gariepy; J L Megnien; N Moatti
Journal:  Am J Cardiol       Date:  1995-01-15       Impact factor: 2.778

10.  Behavior of human apolipoprotein A-I: phospholipid and apoHDL:phospholipid complexes in vitro and after injection into rabbits.

Authors:  J Koizumi; M Kano; K Okabayashi; A Jadhav; G R Thompson
Journal:  J Lipid Res       Date:  1988-11       Impact factor: 5.922

View more
  1 in total

Review 1.  Galleria mellonella infection models for the study of bacterial diseases and for antimicrobial drug testing.

Authors:  Catherine Jia-Yun Tsai; Jacelyn Mei San Loh; Thomas Proft
Journal:  Virulence       Date:  2016-01-05       Impact factor: 5.882

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.